Gossamer Bio regains Nasdaq minimum bid price compliance; deficiency closed.

Gossamer Bio, Inc.

Received Nasdaq notice on Feb 19, 2025 confirming regained compliance with minimum bid price rule.
Previously notified of deficiency on Sept 11, 2024 for failing to maintain $1.00 bid price for 30 days.
Compliance matter now closed; common stock remains listed on Nasdaq Global Select Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.